Anti-PDGFRA Antibodies Predict for Response to Nilotinib in Steroid Refractory / Dependent cGvHD

• Nilotinib has clinical activity in steroid refractory / dependent cGvHD.• Anti-PDGFRA antibodies may predict which patients respond to nilotinib.

Source: Biology of Blood and Marrow Transplantation - October 16, 2017 Category: Hematology Authors: George L. Chen, Paul A. Carpenter, Raewyn Broady, Tara K. Gregory, Laura J. Johnston, Barry E. Storer, Jan H. Beumer, Jingxin Qiu, Kiara Cerda, Ryan Le, Joanne M. Otani, Hong Liu, Maureen A. Ross, Sally Arai, Mary E.D. Flowers, Philip L. McCarthy, David B Source Type: research